A Tampa Bay Lightning fan whom police called on for screaming “shoot!” at the television during the Stanley Cup Final is using the misunderstanding to help raise money for domestic violence organizations.

Devon Garnett, 26, was watching Wednesday’s Game 3 of the Lightning-Dallas Stars series at a friend’s third-floor apartment in Tampa, Forida. The three fans were energized after Lightning star Steven Stamkos, playing in what turned out to be his only game of the postseason due to injury, scored an early goal.

On an ensuing power play, a fired-up Garnett recalled watching Lightning defenseman Victor Hedman hold the puck for too long.

“I was yelling, ‘Shoot! Shoot!’ because sometimes we get too cute with the puck,” he said.

This prompted his neighbor downstairs to call the Hillsborough County Sheriff’s Office, believing there was a domestic dispute involving a firearm. According to sheriff’s office spokesperson Natalia Verdina, four deputies were dispatched to the apartment at 8:24 p.m. after the call. When police showed up, Garnett said they asked where “the guns were” because they were told there was a domestic dispute.

The fans explained the misunderstanding, opening the apartment door wide to show that the game was on television and showing them that they were decked out in Lightning gear.

“My exact words [to them] were, ‘We’re just cheering for Steven Stamkos,'” Garnett said. “They completely understood. Didn’t give us a hard time at all. The whole interaction, from when my friend answered the door and realizing it was the cops to them leaving, was maybe two minutes.”

The story spread among Tampa media and soon went viral, to the point where the Lightning invited Garnett and his friends to watch Game 4 of the Stanley Cup Final at a party inside Amalie Arena. Garnett, who works in

Dewpoint Therapeutics announced Tuesday that it has raised $77 million in its second round of venture funding, which will help the company continue to target “undruggable” diseases through an emerging field in cell biology.

The Boston-based biotech works on organelles inside cells called biomolecular condensates, which it believes can be harnessed to treat diseases including cancer and rare genetic disorders. Condensates are membrane-less droplets that help cells perform vital functions.

The funding round was led by Chicago-based ARCH Venture Partners, bringing Dewpoint’s total venture financing to $137 million. The deal attracted new investors Maverick Ventures and Bellco Capital, and previous investors Leaps by Bayer, EcoR1 Capital, Polaris Partners, Samsara BioCapital, and Innovation Endeavors also participated in the round.

“Today’s announcement underscores the interest in biomolecular condensates among investors with a track record of backing groundbreaking science,” Amir Nashat, managing partner of Polaris Partners and interim chief executive of Dewpoint, said in a news release.

Since its founding in 2018, Dewpoint has signed deals with two pharmaceutical giants. In July, Dewpoint announced a collaboration with Merck & Co. to work on the treatment of HIV, and in November, Dewpoint announced it would work with German pharmaceutical company Bayer to develop new treatments for cardiovascular and gynecological diseases.

Dewpoint also announced Tuesday that Giuseppe Ciaramella, the president and chief scientific officer of Beam Therapeutics, would join its board of directors. Prior to Beam, Ciaramella worked at Moderna in Cambridge, first as head of immunology and biotherapeutics and then as chief scientific officer of its infectious diseases division.

Anissa Gardizy can be reached at [email protected] Follow her on Twitter @anissagardizy8.

Source Article

LONG BEACH, Calif., Sept. 28, 2020 /PRNewswire/ — Coverance Insurance Solutions is pleased to announce a $10.5 million financing led by CUNA Mutual Group, with participation from existing investor Strandview Capital.  Coverance is an independent insurance agency that helps seniors navigate the complex Medicare insurance market to obtain the optimal policy and save money.  CUNA Mutual Group is a leading insurance, financial services and technology company that helps credit unions provide their members with the solutions to attain financial security through all life stages. 

Coverance Insurance Celebrity Spokesperson, Actor, Kelsey Grammer.

“We are very excited to work with CUNA Mutual Group and explore opportunities to offer Medicare insurance options to credit union members”, said Chris Mullins, CEO and founder of Coverance.  “We use senior-focused marketing, data analytics and automation to improve how seniors purchase Medicare insurance.”

Coverance is rapidly building a trusted brand with its celebrity spokesperson Kelsey Grammer, from television shows Cheers and Fraser.  The current COVID-19 pandemic highlights the critical importance of proper Medicare insurance for seniors and has accelerated the trend toward centralized call centers versus how much of the industry has been traditionally served through in-person insurance agents.

CMFG Ventures, the venture capital arm of CUNA Mutual Group, led the financing and recognizes the importance of Medicare insurance to consumers.  “We invested in Coverance because of their commitment to helping seniors obtain the right Medicare Insurance policy to meet their individual needs”, said Brian Kaas, President of CMFG Ventures.  CUNA Mutual Group has $25 billion in assets and offers consumer and commercial insurance, retirement and investment solutions, and business solutions including data and analytics, lending capabilities and marketing services.

The U.S. Medicare Insurance market is estimated at over $24 billion and growing rapidly.  Over 50 million people qualify for Medicare Insurance, and over 10,000 seniors turn 65 every day. 

This morning, Noyo, a startup that provides APIs that link players in the health insurance space, announced that it has closed a $12.5 million Series A round of funding. 

The new capital comes less than a year after the startup disclosed that it had raised around $4 million in pre-seed and seed capital, and that its product was already in the market.

At the time it was clear that Noyo had a laser focus on its part of the healthcare world. Now, nearly a year later, the company confirmed to TechCrunch during conversations surrounding its new capital raise that it’s keeping its focus for now.

Linking the carriers and platforms of other insurance verticals, or varietals, will have to wait.

But Noyo is working in an enormous market, namely the U.S. health insurance universe, one that could provide it with space to grow for years to come. The startup sells the use of its application programming interfaces, or APIs, which in Noyo’s case allow customers to “execute, track, and confirm the fulfillment of member transaction requests to carriers,” citing the startup’s documentation

The company’s product was born out of frustration that Noyo co-founders Shannon Goggin and Dennis Lee dealt with while working for Zenefits, an HR tech unicorn that ran into problems with regulators and customers alike. For more on that story, our prior reporting is useful. (Notably, AgentSync is another API startup play under construction by Zenefits alums.)

The American healthcare market is enormous, lucrative and fraught with inefficiencies and antiquated technology. And the insurance portion of the healthcare market is similarly titanic and broken, providing an outsize opportunity for a startup that can navigate its politics and unique needs with a technology solution able to help incumbents speed up, and save money.

The Series A